資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

頁面路徑選單

Dermatitis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

  • LinkedIn
  • facebook
  • Twitter
出 版 商:TBRC
出版日期:2020/09/09
頁  數:200頁
文件格式:PDF
價  格:
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
線上訂購或諮詢
Dermatitis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global dermatitis drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase
‧ Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
‧ Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Identify growth segments for investment.
‧ Outperform competitors using forecast data and the drivers and trends shaping the market.
‧ Understand customers based on the latest market research findings.
‧ Benchmark performance against key competitors.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the dermatitis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Dermatitis Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
‧ The Market Characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Drug Class: Corticosteroids; Emollients/Moisturizers; Antihistamines; Calcineurin Inhibitors; Antibiotics; Immunomodulators; Interleukin Inhibitors
2) By Distribution Channel: Hospital; Retail Pharmacies; Drug Stores; Online Or Mail Pharmacies
3) By Route Of Application: Topical; Oral; Injectable
4) By Application: Cancer; Blood Disorders; Chronic Diseases; Infectious Diseases

Companies Mentioned: LEO Pharma A/S; Novartis AG; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi S.A.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Executive Summary
2. Dermatitis Drugs Market Characteristics
3. Dermatitis Drugs Market Size And Growth
3.1. Global Dermatitis Drugs Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Dermatitis Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Dermatitis Drugs Market Segmentation
4.1. Global Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Corticosteroids
Emollients/Moisturizers
Antihistamines
Calcineurin Inhibitors
Antibiotics
Immunomodulators
Interleukin Inhibitors
4.2. Global Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospital
Retail Pharmacies
Drug Stores
Online Or Mail Pharmacies
4.3. Global Dermatitis Drugs Market, Segmentation By Route Of Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Topical
Oral
Injectable
4.4. Global Dermatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Cancer
Blood Disorders
Chronic Diseases
Infectious Diseases
5. Dermatitis Drugs Market Regional And Country Analysis
5.1. Global Dermatitis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Dermatitis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Dermatitis Drugs Market
6.1. Asia-Pacific Dermatitis Drugs Market Overview
6.2. Asia-Pacific Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Dermatitis Drugs Market
7.1. China Dermatitis Drugs Market Overview
7.2. China Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Dermatitis Drugs Market
8.1. India Dermatitis Drugs Market Overview
8.2. India Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Dermatitis Drugs Market
9.1. Japan Dermatitis Drugs Market Overview
9.2. Japan Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Dermatitis Drugs Market
10.1. Australia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Dermatitis Drugs Market
11.1. Indonesia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Dermatitis Drugs Market
12.1. South Korea Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Dermatitis Drugs Market
13.1. Western Europe Dermatitis Drugs Market Overview
13.2. Western Europe Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Dermatitis Drugs Market
14.1. UK Dermatitis Drugs Market Overview
14.2. UK Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Dermatitis Drugs Market
15.1. Germany Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Dermatitis Drugs Market
16.4. France Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Dermatitis Drugs Market
17.1. Eastern Europe Dermatitis Drugs Market Overview
17.2. Eastern Europe Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Dermatitis Drugs Market
18.1. Russia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Dermatitis Drugs Market
19.1. North America Dermatitis Drugs Market Overview
19.2. North America Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Dermatitis Drugs Market
20.1. USA Dermatitis Drugs Market Overview
20.2. USA Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Dermatitis Drugs Market
21.1. South America Dermatitis Drugs Market Overview
21.2. South America Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Dermatitis Drugs Market
22.1. Brazil Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Dermatitis Drugs Market
23.1. Middle East Dermatitis Drugs Market Overview
23.2. Middle East Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Dermatitis Drugs Market
24.1. Africa Dermatitis Drugs Market Overview
24.2. Africa Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Dermatitis Drugs Market Competitive Landscape And Company Profiles
25.1. Dermatitis Drugs Market Competitive Landscape
25.2. Dermatitis Drugs Market Company Profiles
25.2.1. LEO Pharma A/S
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Novartis AG
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Pfizer Inc.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Regeneron Pharmaceuticals Inc.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Sanofi S.A.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Dermatitis Drugs Market
27. Dermatitis Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Dermatitis Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

回上頁